USA flag logo/image

An Official Website of the United States Government

CHARACTERIZATION OF NANO-SCALE PHARMACEUTICAL POWDERS *

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
61023
Program Year/Program:
2002 / SBIR
Agency Tracking Number:
GM065785
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
SYNERGETIC TECHNOLOGIES, INC.
SYNERGETIC TECHNOLOGIES, INC. 1 UNIVERSITY PL, STE D210 RENSSELAER, NY 12144
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2002
Title: CHARACTERIZATION OF NANO-SCALE PHARMACEUTICAL POWDERS *
Agency: HHS
Contract: 1R43GM065785-01
Award Amount: $99,997.00
 

Abstract:

DESCRIPTION (provided by applicant): This project proposes to further develop and test Synergetic Technologies (Synergetics) novel system for characterizing pharmaceutical powders and their agglomerates. Nanopowder drug formulations exhibit increased bioavailability and offer unlimited potential for drug delivery. Unfortunately, they are difficult to stabilize due to their great surface area and propensity to agglomerate. On-line characterization, an important consideration for drug development and quality, is a major challenge for ultra-fine pharamceutical powders. This fact is underscored by the willingness of a number of drug companies that participate in this project. Based on successful characterization studies of nano and submicron ceramic powders, Synergetics intends to develop a customized pharmaceutical powder characterization tool which will determine particle size, shape, and agglomerate structure from the nano to micro size range. Tasks are focused on development of a customized, information-rich instrument, which will be of great value to the pharmaceutical industry. Phase II will involve construction and testing of prototype devices, extension of important particle dispersion studies begun in Phase I, and on-site testing at pharmaceutical laboratories that have expressed keen interest in employing this technology. This project is a critical step in development and will provide the framework for Phase Ill commercialization. Potential customer interest has been keen, as evidenced by the financial commitments of Phase II and Phase III partners. Manufacturing and licensing plans are well form and will materialize as this project gets underway. Strategic partners include a potential manufacturer and seller (Thermo Oriel-an established leader in photonics manufacturing and sales), major pharmaceutical companies who see great potential value in this technology (Glaxo-Smith-Kline, Elan Pharmaceutical Technologies, Boehringer-lngelheim, and ASSCI) and expert particle characterization scientists from Columbia University and the University at Albany. PROPOSED COMMERCIAL APPLICATION: A vast market exists for instruments provising on-line characterization of pharmaceutical powders. The emergence of nano-size powders for advanced drug delivery introduces new demands and, consequently, a lucrative business opportunity for Synergic Technologies. Additional applications for this technology include advanced materials, consumer products and food processing, and environmental monitoring.

Principal Investigator:

Craig J. Saltiel
5185252650
CSALTIEL@SYNERGETIC-TECH.COM

Business Contact:

Craig Saltiel
5185252650
CSALTIEL@SYNERGETIC-TECH.COM
Small Business Information at Submission:

SYNERGETIC TECHNOLOGIES, INC.
SYNERGETIC TECHNOLOGIES, INC. 1 UNIVERSITY PL, STE D210 RENSSELAER, NY 12144

EIN/Tax ID: 141792440
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No